Optomed PLC Valuation

OPTOMED Stock  EUR 4.23  0.23  5.75%   
At this time, the company appears to be fairly valued. Optomed PLC holds a recent Real Value of €4.34 per share. The prevailing price of the company is €4.23. Our model determines the value of Optomed PLC from analyzing the company fundamentals such as Return On Equity of -0.33, operating margin of (0.50) %, and Shares Outstanding of 16.17 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
4.23
Please note that Optomed PLC's price fluctuation is relatively risky at this time. Calculation of the real value of Optomed PLC is based on 3 months time horizon. Increasing Optomed PLC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Optomed stock is determined by what a typical buyer is willing to pay for full or partial control of Optomed PLC. Since Optomed PLC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Optomed Stock. However, Optomed PLC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  4.23 Real  4.34 Hype  4.23 Naive  3.88
The real value of Optomed Stock, also known as its intrinsic value, is the underlying worth of Optomed PLC Company, which is reflected in its stock price. It is based on Optomed PLC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Optomed PLC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
4.34
Real Value
8.17
Upside
Estimating the potential upside or downside of Optomed PLC helps investors to forecast how Optomed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Optomed PLC more accurately as focusing exclusively on Optomed PLC's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.794.164.52
Details
Hype
Prediction
LowEstimatedHigh
0.404.238.06
Details
Naive
Forecast
LowNext ValueHigh
0.053.887.71
Details

Optomed PLC Total Value Analysis

Optomed PLC is now estimated to have takeover price of 63.93 M with market capitalization of 72.67 M, debt of 5.75 M, and cash on hands of 7.82 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Optomed PLC fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
63.93 M
72.67 M
5.75 M
7.82 M

Optomed PLC Investor Information

About 51.0% of the company shares are owned by institutional investors. The book value of Optomed PLC was now reported as 1.17. The company recorded a loss per share of 0.37. Optomed PLC had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Optomed PLC's historical financial statements, Optomed PLC is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.

Optomed PLC Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Optomed PLC has an asset utilization ratio of 51.21 percent. This indicates that the Company is making €0.51 for each dollar of assets. An increasing asset utilization means that Optomed PLC is more efficient with each dollar of assets it utilizes for everyday operations.

Optomed PLC Ownership Allocation

Optomed PLC owns a total of 16.17 Million outstanding shares. Over half of Optomed PLC's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Optomed PLC. Please watch out for any change in the institutional holdings of Optomed PLC as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Optomed PLC Profitability Analysis

The company reported the revenue of 14.85 M. Net Loss for the year was (4.25 M) with profit before overhead, payroll, taxes, and interest of 10.02 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Optomed PLC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Optomed PLC and how it compares across the competition.

About Optomed PLC Valuation

The stock valuation mechanism determines Optomed PLC's current worth on a weekly basis. Our valuation model uses a comparative analysis of Optomed PLC. We calculate exposure to Optomed PLC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Optomed PLC's related companies.
Optomed Oyj, a medical technology company, provides handheld fundus cameras and eye-screening devices in Finland, China, and internationally. The company was founded in 2004 and is headquartered in Oulu, Finland. Optomed Plc is traded on Helsinki Exchange in Finland.

8 Steps to conduct Optomed PLC's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Optomed PLC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Optomed PLC's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Optomed PLC's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Optomed PLC's revenue streams: Identify Optomed PLC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Optomed PLC's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Optomed PLC's growth potential: Evaluate Optomed PLC's management, business model, and growth potential.
  • Determine Optomed PLC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Optomed PLC's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Optomed Stock analysis

When running Optomed PLC's price analysis, check to measure Optomed PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Optomed PLC is operating at the current time. Most of Optomed PLC's value examination focuses on studying past and present price action to predict the probability of Optomed PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Optomed PLC's price. Additionally, you may evaluate how the addition of Optomed PLC to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Technical Analysis
Check basic technical indicators and analysis based on most latest market data